SARAH DAWSON: Open Payments
NPI 1235764135 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,084 in 50 payments from 28 companies in 2025. Trend: 2023 $2,409 · 2024 $4,918 · 2025 $2,084
Food & beverage: $1,886Education: $198
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $197 |
| Merck Sharp & Dohme LLC | 4 | $194 |
| Syndax Pharmaceuticals, Inc. | 2 | $170 |
| Daiichi Sankyo Inc. | 2 | $164 |
| Regeneron Healthcare Solutions, Inc. | 2 | $147 |
| Pharmacosmos Therapeutics Inc. | 1 | $108 |
| Incyte Corporation | 1 | $99 |
| Gilead Sciences, Inc. | 1 | $99 |
| AstraZeneca Pharmaceuticals LP | 4 | $97 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
Products named: KEYTRUDA, LIBTAYO, DATROWAY, JEMPERLI, MONOFERRIC, Trodelvy, RYTELO, KIMMTRAK.
Industry payments across TX — which companies pay providers there.
